Atomistry » Sodium » PDB 3rnx-3si4 » 3s54
Atomistry »
  Sodium »
    PDB 3rnx-3si4 »
      3s54 »

Sodium in PDB 3s54: Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212

Enzymatic activity of Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212

All present enzymatic activity of Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212:
3.4.23.16;

Protein crystallography data

The structure of Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212, PDB code: 3s54 was solved by Y.-F.Tie, Y.-F.Wang, I.T.Weber, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 10.00 / 1.42
Space group P 21 21 2
Cell size a, b, c (Å), α, β, γ (°) 58.595, 86.161, 46.204, 90.00, 90.00, 90.00
R / Rfree (%) 15.4 / 20.8

Other elements in 3s54:

The structure of Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212 also contains other interesting chemical elements:

Chlorine (Cl) 2 atoms

Sodium Binding Sites:

The binding sites of Sodium atom in the Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212 (pdb code 3s54). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212, PDB code: 3s54:

Sodium binding site 1 out of 1 in 3s54

Go back to Sodium Binding Sites List in 3s54
Sodium binding site 1 out of 1 in the Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Hiv-1 Protease Triple Mutants V32I, I47V, V82I with Antiviral Drug Darunavir in Space Group P21212 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Na501

b:25.0
occ:1.00
O A:HOH1088 2.2 24.9 1.0
O A:HOH1002 2.3 38.3 1.0
O A:ASP60 2.4 17.1 1.0
O A:HOH1097 2.5 25.1 1.0
O A:HOH1087 2.5 22.9 1.0
O A:HOH1101 2.7 38.0 1.0
C A:ASP60 3.4 17.1 1.0
N A:ASP60 3.8 15.2 1.0
O A:HOH1130 3.9 26.4 0.5
CA A:ASP60 4.0 15.9 1.0
O A:ARG41 4.2 22.4 1.0
CB A:GLN61 4.4 19.5 1.0
N A:GLN61 4.5 16.0 1.0
CB A:ASP60 4.5 19.0 1.0
N A:ARG41 4.5 25.3 1.0
CD1 A:ILE62 4.6 19.6 1.0
O A:PRO39 4.6 24.3 1.0
C A:TYR59 4.7 12.5 1.0
O A:GLN61 4.7 22.6 1.0
CA A:GLN61 4.8 17.8 1.0
C A:GLN61 4.8 17.0 1.0
CA A:GLY40 4.8 25.0 1.0
CG A:ARG41 4.8 46.3 1.0
C A:GLY40 5.0 25.0 1.0

Reference:

Y.Tie, Y.F.Wang, P.I.Boross, T.Y.Chiu, A.K.Ghosh, J.Tozser, J.M.Louis, R.W.Harrison, I.T.Weber. Critical Differences in Hiv-1 and Hiv-2 Protease Specificity For Clinical Inhibitors. Protein Sci. V. 21 339 2012.
ISSN: ISSN 0961-8368
PubMed: 22238126
DOI: 10.1002/PRO.2019
Page generated: Tue Dec 15 06:24:22 2020

Last articles

Zn in 7VD8
Zn in 7V1R
Zn in 7V1Q
Zn in 7VPF
Zn in 7T85
Zn in 7T5F
Zn in 7NF9
Zn in 7M4M
Zn in 7M4O
Zn in 7M4N
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy